26th Jun 2020 06:52
(Alliance News) - RUA Life Sciences PLC on Thursday announced the first surgical implant of its Elast-Eon sealed vascular graft into an animal.
Based in Glasgow, Scotland, RUA is the holding company of a group of medical device businesses focused around the use of Elast-Eon. This polymer is implantable long-term and is biostable, meaning is keeps its integrity after implantation.
According to RUE, the implantation was successful and the graft met its primary targets of blood sealing and suture line performance.
RUA is intending to examine the healing of the graft as compared to a control as a secondary target.
The implantation was part of RUE's prototype evaluation before the graft design is frozen. Based on initial findings from the implant, RUE has made "alterations to the selvedge line" for the grafts intended for phase 2 of the study. This second phase will start "as soon as possible".
Chair Bill Brown said: "First animal implant is always a major milestone in the development of new medical devices and we are delighted to have successfully sealed a textile graft with Elast-Eon. This brings us another step closer to reaching design freeze and moving forward to regulatory testing."
Shares in RUA ended 4.7% lower at 121.50 pence in London on Thursday.
By Anna Farley; [email protected]
Copyright 2020 Alliance News Limited. All Rights Reserved.
Related Shares:
Rua Life Sci.